U.S. Ophthalmic Eye Droppers Market Size & Outlook
U.S. ophthalmic eye droppers market, 2018-2030 (US$M)
Related Markets
U.S. ophthalmic eye droppers market highlights
- The U.S. ophthalmic eye droppers market generated a revenue of USD 5,007.0 million in 2023 and is expected to reach USD 7,518.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6% from 2024 to 2030.
- In terms of segment, preserved multi-dose eye droppers was the largest revenue generating type in 2023.
- Preservative-free multi-dose eye droppers is the most lucrative type segment registering the fastest growth during the forecast period.
Ophthalmic eye droppers market data book summary
| Market revenue in 2023 | USD 5,007.0 million |
| Market revenue in 2030 | USD 7,518.7 million |
| Growth rate | 6% (CAGR from 2023 to 2030) |
| Largest segment | Preserved multi-dose eye droppers |
| Fastest growing segment | Preservative-free multi-dose eye droppers |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Unidose eye droppers, Preserved multi-dose eye droppers, Preservative-free multi-dose eye droppers |
| Key market players worldwide | AptarGroup Inc, Silgan Holdings Inc, Alcon Inc, Pfizer Inc, Bausch & Lomb Corp, Novartis AG ADR, AbbVie Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 37.3% of the global ophthalmic eye droppers market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. ophthalmic eye droppers market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,545.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Ophthalmic Eye Droppers Market Scope
Ophthalmic Eye Droppers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. ophthalmic eye droppers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic eye droppers market will help companies and investors design strategic landscapes.
Preserved multi-dose eye droppers was the largest segment with a revenue share of 46.52% in 2023. Horizon Databook has segmented the U.S. ophthalmic eye droppers market based on unidose eye droppers, preserved multi-dose eye droppers, preservative-free multi-dose eye droppers covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of ophthalmic conditions in the country and the presence of major players are the key factors boosting the market growth in the U.S. The rising prevalence of Dry Eye Disease (DED) in the U.S. continues to grow at a rapid pace, creating an increased demand for ophthalmic eye droppers.
The presence of key players ensures the rapid availability of advanced technologies in the region. For instance, in September 2023, Bausch+Lomb Corporation launched MIEBO (perfluorohexyloctane ophthalmic solution) for treating the indications and symptoms of DED in the U.S. Moreover, MIEBO stands as the initial and sole prescription eye drop sanctioned for DED, specifically targeting tear evaporation.
Reasons to subscribe to U.S. ophthalmic eye droppers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. ophthalmic eye droppers market databook
-
Our clientele includes a mix of ophthalmic eye droppers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. ophthalmic eye droppers market , including forecasts for subscribers. This country databook contains high-level insights into U.S. ophthalmic eye droppers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. ophthalmic eye droppers market size, by type, 2018-2030 (US$M)
U.S. Ophthalmic Eye Droppers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
